Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 1/20 | 0.57 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.57 |
| ▸ | CRHR1 | P34998 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.47 |
| ▸ | GBA1 | P04062 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10055002 | 1.00 | CARM1 (0.57) | CARM1PRMT6CRHR1NPC1RAB9A | |
| SCHEMBL18434523 | 1.00 | CARM1 (0.57) | CARM1PRMT6CRHR1NPC1RAB9A | |
| SCHEMBL10055063 | 1.00 | CARM1 (0.57) | CARM1PRMT6CRHR1NPC1RAB9A | |
| SCHEMBL872221 | 0.91 | CARM1 (0.54) | CARM1PRMT6CRHR1NPC1RAB9A | |
| SCHEMBL9679337 | 0.91 | EPHX1 (0.54) | CARM1PRMT6CRHR1NPC1RAB9A | |
| SCHEMBL1846502 | 0.90 | CARM1 (0.50) | CARM1PRMT6CRHR1NPC1RAB9A | |
| SCHEMBL13493826 | 0.90 | CARM1 (0.54) | CARM1PRMT6CRHR1NPC1RAB9A | |
| SCHEMBL543334 | 0.90 | CARM1 (0.50) | CARM1PRMT6CRHR1NPC1RAB9A | |
| SCHEMBL23845320 | 0.89 | EPHX1 (0.57) | CARM1PRMT6CRHR1NPC1RAB9A | |
| SCHEMBL901572 | 0.89 | EPHX1 (0.57) | CARM1PRMT6CRHR1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114591192-B | Preparation method of N-cyclopropylmethyl aniline compound | 江西仰立新材料有限公司 | 2024-06-21 | — | — | CN | claimed |
| US-11407710-B2 | Method for preparing an N-cyclopropylmethyl aniline compound | Jiangxi Univate New Material Co., LTD. | 2022-08-09 | — | — | US | claimed |
| CN-112707837-B | Preparation method of N-cyclopropylmethylaniline compound | 长沙嘉桥生物科技有限公司 | 2022-07-19 | — | — | CN | claimed |
| US-20220177414-A1 | METHOD FOR PREPARING AN N-CYCLOPROPYLMETHYL ANILINE COMPOUND | Jiangxi Univate New Material Co., LTD. (CN) | 2022-06-09 | — | — | US | claimed |
| CN-114591192-A | Preparation method of N-cyclopropylmethylaniline compound | 江西仰立新材料有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-112707837-A | Preparation method of N-cyclopropylmethylaniline compound | 长沙嘉桥生物科技有限公司 | 2021-04-27 | — | — | CN | claimed |
| WO-2002070507-A2 | GLYCORTICOID RECEPTOR ANTAGONISTS FOR TREATMENT OF DIABETES | ABBOTT LABORATORIES (US) | 2002-09-12 | — | — | WO | claimed |
| US-20250361236-A9 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | GILEAD SCIENCES INC (US) | 2025-11-27 | — | — | US | disclosed |
| CN-119899088-A | Method for preparing cyclopropyl formaldehyde derivative by electrically-promoted ring contraction of alkenyl cyclobutyl alcohol | 重庆医科大学 | 2025-04-29 | — | — | CN | disclosed |
| US-20240400568-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | GILEAD SCIENCES, INC. | 2024-12-05 | — | — | US | disclosed |
| EP-4445902-A2 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | Carna Biosciences, Inc. (JP) | 2024-10-16 | — | — | EP | disclosed |
| EP-4081305-B1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | CARNA BIOSCIENCES INC (JP) | 2024-09-18 | — | — | EP | disclosed |
| US-12054490-B2 | Diacylglycerol kinase modulating compounds | GILEAD SCIENCES, INC. (US) | 2024-08-06 | — | — | US | disclosed |
| US-5552404-A | COMPOUNDS FOR NEUROTRANSMITTERS FOR ANIMALS | DELTA PHARMACEUTICALS, INC. (US) | 1996-09-03 | — | — | US | disclosed |
| EP-0711289-A1 | PIPERAZINE COMPOUNDS USED IN THERAPY | DELTA PHARMACEUTICALS, INC. (US) | 1996-05-15 | — | — | EP | disclosed |
| WO-1995004051-A1 | PIPERAZINE COMPOUNDS USED IN THERAPY | THE WELLCOME FOUNDATION LIMITED (GB) | 1995-02-09 | — | — | WO | disclosed |
| EP-0598962-A1 | Imidazole derivatives as calcium channel blockers | NEUROSEARCH A/S (DK) | 1994-06-01 | — | — | EP | disclosed |
| US-5296493-A | Analgesics or antiischemics | NEUROSEARCH A/S (DK) | 1994-03-22 | — | — | US | disclosed |
| US-4077968-A | ANTIINFLAMMATORY, ANTIRHEUMATIC, ANALGESIC, ANTILIPEMIC | SHIONOGI & CO., LTD. (JA) | 1978-03-07 | — | — | US | disclosed |
| US-4025528-A | ANTIINFLAMMATORY, ANALGESIC, ANTILIPEMIC | SHIONOGI & CO., LTD. (JA) | 1977-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400568-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | DGKG, DGKB, DGKK | CARM1 2598/4885PRMT6 1544/4885CRHR1 4417/4885 |
| US-11407710-B2 | Method for preparing an N-cyclopropylmethyl aniline compound | PPOX, HAAO, DAO | CARM1 203/4885PRMT6 256/4885CRHR1 2443/4885 |
| US-12054490-B2 | Diacylglycerol kinase modulating compounds | DGKG, DGKB, DGKK | CARM1 2598/4885PRMT6 1544/4885CRHR1 4417/4885 |
| US-20220177414-A1 | METHOD FOR PREPARING AN N-CYCLOPROPYLMETHYL ANILINE COMPOUND | PPOX, HAAO, DAO | CARM1 203/4885PRMT6 256/4885CRHR1 2443/4885 |
| US-20250361236-A9 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | DGKG, DGKB, DGKK | CARM1 2598/4885PRMT6 1544/4885CRHR1 4417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.